Great result considering how close we've been to the edge lately.
Cash received from customers increased 781% quarter on quarter. To finish the Qtr with only $96k in negative cashflow is a massive turnaround from the September Qtr of -$13.6 million. Without the cost associated with the purchase of non-current assets of $4 million they could of funded the Qtr without raising any cash at all. I admit it would of only pushed the raise into this Qtr but who knows what the deal with Amgen involves cash wise. Finished the Qtr with $20.3 million which was good to see a little cash in the bank. Great turnaround I feel..... Although it would of been great to have a small operating profit, only needed to find another $100k.
Sign of things to come hopefully. Bring on the Qtr on Qtr, YoY growth moving forward
Goodluck guys.
Can't wait to see this announcement Monday.
UNS Price at posting:
22.0¢ Sentiment: Buy Disclosure: Held
